Xanthan and locust bean gum (from Ceratonia siliqua) matrix tablets for oral controlled delivery of metoprolol tartrate

Current Drug Therapy

Volumn 3, Issue 1, 2008, Pages 70-77

  Venkataraju, M P ^a   Gowda, D V ^a   Rajesh, K S ^b   Shivakumar, H G ^a  

^a JSS COLLEGE OF PHARMACY   (India)

^b Parul Institute of Pharmacy and Research   (India)

Author keywords

Controlled release; Locust bean gun; Metoprolol tartrate; Xantham gum

Indexed keywords

ALGAROBA; CALCIUM PHOSPHATE DIBASIC; MAGNESIUM STEARATE; METOPROLOL TARTRATE; POLYMER; TALC; XANTHAN;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; IN VITRO STUDY; MATRIX TABLET; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TABLET FORMULATION; TABLET HARDNESS; THERMOGRAPHY;

EID: 38949131440     PISSN: 15748855     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488508783331216     Document Type: Review

References (37)

1. Bhardwaj TR, Kanwar M, Lad R, Gupta A. Natural gums and modified natural gum as sustained-release carriers. Drug Dev Ind Pharm 2000; 26(10): 1025-1038.
2. Billa N, Yuen KH. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharma Sci Tech (2000); 1(4): 1-8.
3. Munday DL, Cox PJ. Compressed xanthan and karaya gum matrices: hydration, erosion and drug release mechanisms. Int J Pharm 2000; 203: 179-192.
4. Talukdar MM, Van den Mooter G, Augustijns P, Tjandra-Maga T, Verbeke N, Kinget R. In vitro evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formulation. Int J Pharm 1998; 169: 105-113.
5. Morris V. Bacterial polysaccharides, In Food Polysaccharides and Their Applications. New York, NY: Marcel Dekker Inc; 1995; 478-493.
6. Toko M. Synergistic interaction between deacetylated xanthan and galactomannan. J Carbohydr 1991; 10: 619-633.
7. Bresolin TMB, Sander PC, Reicher F, Sierakowski MR, Rinaudo M, Ganter JLMS. Viscometric studies on xanthan and galactomannan systems. Carbohydr Polym 1997; 33: 131-138.
8. Bresolin TMB, Milas M, Rinaudo M, Reicher F, Ganter LMS. Role of galactomannan composition on the binary gel formation with xanthan. Int J Biol Macromol 1999; 26: 225-231.
9. Colombo P, Conte U, Caramella C, Gazzaniga. A, La Manna A. Compressed polymeric mini-matrices for drug release control. J Control Release 1985; 1: 283-289.
10. Staniforth JN, Baichwal AR. Synergistically interacting heterodisperse polysaccharides. In polymer delivery systems, ACS Symposium Series; American Chemical Society. USA: 1993; 520: 327-350.
11. Welling PG. Effect of food on drug absorption. Annu Rev Nutr 1996; 16: 383-415.
12. Oosterhuis B, Jonkman JLH. Pharmacokinetics studies in healthy volunteers in the context of in vitro/in vivo correlations. Eur J Drug Metab Pharmacokinet 1993; 18: 19-30.
13. Abrahamsson B, Alpsten M, Bake B, et al. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet compression with osmotic pump tablet and effect of food. J Control Release 1998; 52(3): 301-310.
14. Gai MN, Isla A, Andonaegui MT, Thielemann AM, Seitz C. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets. Int J Clin Pharmacol Ther 1997; 35(12): 565-571.
15. Abrahamsson B, Roos K, Sjogren J. Investigation of prandial effect on hydrophilic matrix tablets. Drug Dev Ind Pharm 1999; 25: 765-771.
16. Nurnberg E, Retting E. On the characterisation of hydrocolloidal slow-release tablets illustrated for the example "Danaden® retard" tablets. Drugs Made Germ 1974; 17; 26.
17. Cox PJ, Khan KA, Munday DL, Sujja-areevath J. Development and evaluation of a multiple-unit release dosage form for S (+)- ibuprofen: preparation and release kinetics. Int J Pharm 1999; 193: 73-84.
18. Sujja-areevath J, Munday DL, Cox PJ, Khan KA. Relationship between swelling, erosion and drug release in bydrophilic natural gum mini-matrix formulations. Eur J Pharm Sci 1998; 6: 207-217.
19. Talukdar MM, Kinget R. Comparative study on xanthan gum and hydroxypropyl methylcellulose as matrices for controlled-release drug delivigy: II drug diffusion in hydrated matrices. Int J Pharm 1997; 151: 99-107.
20. Dea ICM, Morrison A. Chemistry and interactions of seed galactomannans. Adv Carbohydr Chem Biochem 1975; 31: 242-312.
21. Morris ER. Mixed polymer gels. In: Harris P, ed. Food gels. London, Elsevier Applied Science; 1990; 291-360.
22. Launay B, Doublier JR, Cuvelier G. Flow properties of aqueous solutions and dispersions of polysaccharides. In: Mitchell JR, Ledward DA, ed. Functional properties of food macromolecules. London, Elsevier Applied Science; 1986; 1-78.
23. Haskell WL, Spiller GA, Jensen CD, Ellis BK, Gates JE. Role of water-soluble, dietary fiber in the management of elevated plasma cholesterol in healthy subjects. Am J Cardiol 1992; 5(69): 433-439.
24. Dayer P, Leemann T, Marmy A, Rosenthater J. Indterindividual variation of beta-adrenoreceptor blocking drugs, plasma concentrations and effect: influence of genetic status on behaviour of atenolol, bopindolol and metoprolol. Eur J Clin Pharmacol 1985; 28: 149-153.
25. McGowity JC, Silas JH, Lennard MS, Tucker GT, Woods HF. Metoprolol metabolism add debrisoquine oxidation polymorphism-population and family studies. Br J Clin Pharmacol 1985; 20: 555-566.
26. Harland RS, Gazzaniga A, Sanagalli ME, Colombo P, Peppas NA. Drug/ polymer matrix swelling and dissolution. Pharm Res 1988; 5(8): 488-494.
27. Peppas NA, Sahlin JJ. A simple equation for the description of sustained release III Coupling of diffusion and relaxation. Int J Pharm 1989; 57: 169-172.
28. Lee PL, Kim CJ. Probing the mechanism of drug release from hydrogels. J Control Release 1991; 16: 229-236.
29. Reynolds TD, Gehrke SH, Hussain AS, Shenouda LS. Polymer erosion and drug release characterization of hydroxypropylmethyl-cellulose matrices. J Pharm Sci 1998; 87(9): 1115-1123.
30. Efentakis M, Loutlis A. Release of furosemide from multiple-unit and single-unit preparations containing different viscosity grades of sodium alginate. Pharm Dev Technol 2001; 6: 91-98.
31. Korsmeyer RW, Peppas NA. Macromolecular and modeling aspects of swelling-controlled systems. In: Roseman, TS, Mansdorf SZ, ed. Controlled Release Delivery Systems. New York, Marcel Dekker; 1981; 77-90.
32. Ritger, PL, Peppas NA. A simple equation for description of solute release II Fickian and anomalous from swellable devices. J Control Release 1987; 5: 37-42.
33. Eddy CG, Antonio IC, Bernard B, Jose LP, Fernand R, Jyrki H. Development and optimization of a novel sustained-release dextran tablet formulation for Propranolol hydrochloride. Int J Pharm 2006; 317: 32-39.
34. Longxiao Liu, Binjie C. Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur J Pharmacol 2006; 64: 180-184.
35. Billa N, Yuen KH. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale. AAPS Pharma Sci Tech 2000; 1(4): 1-8.
36. Hogan JE. Hydroxypropylmethylcellulose sustained release technology. Drug Dev Ind Pharm 1989; 15: 975-999.
37. Khullar P, Khar R, Agarwal SP. Evaluation of guar gum in the preparation of sustained-release matrix tablets. Drug Dev Ind Pharm 1998; 24(11): 1095-1099.